Prostatic cancer. Treatment with LH-RH analogs
Ogreid, P.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 106(34-36): 2968-2970
1986
ISSN/ISBN: 0029-2001 PMID: 3544333 Document Number: 281188
Document emailed within 1 workday
Related Documents
Forti, G.; Serio, M. 1990: Gn-RH analogs and benign prostatic hypertrophy Drugs under Experimental and Clinical Research 16(Suppl): 31-32Hao, X.K. 1993: Radioimmunodetection of prostatic cancer: in vivo 131I-gamma-seminoprotein for diagnosis of prostatic cancer by nuclear imaging Zhonghua Yi Xue Za Zhi 73(11): 655-657; 700
Oishi, K.; Arai, Y.; Takeuchi, H.; Yoshida, O. 1993: Side effects of estrogen administration to prostatic cancer patients: clinical and statistical survey of 109 prostatic cancer cases of Kyoto University Hospital Hinyokika Kiyo. Acta Urologica Japonica 39(1): 23-28
Milczarek, M.; Rosinska, S.; Psurski, M.; Maciejewska, M.; Kutner, A.; Wietrzyk, J. 2013: Combined colonic cancer treatment with vitamin D analogs and irinotecan or oxaliplatin Anticancer Research 33(2): 433-444
Bessoule, O.; Le Loët, X.; Deshayes, P. 1988: Importance of analogs of LHRH in the treatment of bone metastasis of cancer of the prostate in 1988 Revue du Rhumatisme et des Maladies Osteo-Articulaires 55(11): 885-887
Lehtonen, T.; Mäntylä, M. 1979: Treatment of prostatic cancer Duodecim; Laaketieteellinen Aikakauskirja 95(12): 760-767
Bertelli, A. 1990: Introduction: recent progress in therapy of prostatic carcinoma and other hormone dependent pathology with the use of agonistic analogs of LHRH Drugs under Experimental and Clinical Research 16(Suppl): 1-2
Ballanger, R.; Ballanger, P. 1980: Treatment of prostatic cancer with radiotherapy Acta Urologica Belgica 48(1): 86-91
Rutkowski, A. 1980: Problems of treatment of prostatic cancer Wiadomosci Lekarskie 33(18): 1461-1466
Khazanov, V.G. 1989: The diagnosis and treatment of prostatic cancer Fel'dsher i Akusherka 54(6): 24-26
Fosså, S.D.; Miller, A. 1975: Treatment of advanced prostatic cancer Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 95(13): 811-814
Paul, B.D.; Serrano, J.A.; Friedman, A.E.; Sarlos, I.J.; Sternberger, N.J.; Wasserkrug, H.L.; Seligman, A.M. 1977: New agents for prostatic cancer activated specifically by prostatic acid phosphatase Cancer Treatment Reports 61(2): 259-263
Gu, F. 2000: Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China Chinese Medical Journal 113(4): 299-302
Rodríguez Rodríguez, R.; Mayayo Dehesa, T.; Galbis Sanjuan, F.; Burgos Revilla, F.J.; Jiménez Cidre, M.; García González, R. 1996: Chronic prostatic inflammation: a confounding factor in the diagnosis of prostatic cancer Archivos Espanoles de Urologia 49(7): 669-673
Goldenberg, D.M.; DeLand, F.H. 1984: Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase Urologic Clinics of North America 11(2): 277-281
Simonin, R.; Nicolino-Peltier, C.; Gainlet, P. 1989: Gonadorelin analogs combined with anti-androgens in the treatment of bone metastasis from prostate cancer. can their use induce osteoporosis? Presse Medicale 18(41): 2023
Murray, R.; Pitt, P. 1987: Aminoglutethimide in the treatment of advanced prostatic cancer Progress in Clinical and Biological Research 243a: 275-282
Auclerc, G. 2000: General treatment of metastatic prostatic cancer Annales d'Urologie 34(1): 39-48
Murphy, G.P. 1987: To what degree is chemotherapy useful in the treatment of prostatic cancer Progress in Clinical and Biological Research 243b: 247-253
Teni, T.R.; Bandivdekar, A.H.; Sheth, A.R.; Sheth, N.A. 1989: Prostatic inhibin-like peptide quantified in urine of prostatic cancer patients by enzyme-linked immunosorbent assay Clinical Chemistry 35(7): 1376-1379